Saturna Capital Invests $531,000 In WuXi PharmaTech
Saturna Capital acquired a new position in shares of WuXi PharmaTech (Cayman) Inc. (NYSE:WX) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 12,300 shares of the company’s stock, valued at approximately $531,000.